Zhao-Qiu Wu

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 4

Top Topics

Cancer Stem Cells

Transforming Growth Factor

Protein Protein

Top Venues

British journal of pharmacology

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Li-Zhi Cheng, Dan-Ling Huang, Zhang-Rui Tang, Jia-Hao Zhang, Ting Xiong, Chen Zhou, Nai-Xia Zhang, Rong Fu, Yong-Xian Cheng, Zhao-Qiu Wu
Pharmacological targeting of Axin2 suppresses cell growth and metastasis in colorectal cancer. British journal of pharmacology (2023)
Bo-Xue Ren, Yang Li, Hong-Mei Li, Tao Lu, Zhao-Qiu Wu, Rong Fu
The Antibiotic Drug Trimethoprim Suppresses Tumor Growth and Metastasis via Targeting Snail. British journal of pharmacology (2021)
Hong-Mei Li, Yan-Ran Bi, Yang Li, Rong Fu, Wen-Cong Lv, Nan Jiang, Ying Xu, Bo-Xue Ren, Ya-Dong Chen, Hui Xie, Shui Wang, Tao Lu, Zhao-Qiu Wu
A potent CBP/p300-Snail interaction inhibitor suppresses tumor growth and metastasis in wild-type p53-expressing cancer. Science advances 6 (17) (2020)
Rong Fu, Yi-Wei Zhang, Hong-Mei Li, Wen-Cong Lv, Li Zhao, Qing-Long Guo, Tao Lu, Stephen J Weiss, Zhi-Yu Li, Zhao-Qiu Wu
LW106, a novel indoleamine 2,3-dioxygenase 1 inhibitor, suppresses tumour progression by limiting stroma-immune crosstalk and cancer stem cell enrichment in tumour micro-environment. British journal of pharmacology 175 (14) (2018)